Lamivudine treatment for fulminant hepatic failure due to acute exacerbation of chronic hepatitis B infection

Abstract

Lamivudine may be useful in treating patients with fulminant hepatic failure due to exacerbation of chronic hepatitis B. Hepatitis B e antigen seroconversion was less durable in this subgroup of patients and long-term therapy may be required.